An oxaliplatin-based phase II randomized study of induction chemotherapy followed by preoperative chemoradiotherapy or preoperative chemoradiotherapy in patients with resectable esophageal or gastroesophageal carcinoma
Phase of Trial: Phase II
Latest Information Update: 12 Feb 2015
At a glance
- Drugs Oxaliplatin (Primary) ; Fluorouracil
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Nov 2012 Planned end date changed from 1 Apr 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.
- 11 Nov 2011 Planned End Date changed from 1 Apr 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov.